Osteonecrosis of the Jaw in a Patient with Osteoporosis Treated with Oral Bisphosphonates / 대한정형외과학회잡지
The Journal of the Korean Orthopaedic Association
;
: 151-154, 2010.
Artigo
em Coreano
| WPRIM
| ID: wpr-651835
ABSTRACT
Bisphosphonates are widely used in the management of metastatic bone disease and in the prevention of osteomalacia and osteoporosis. In particular, oral preparations are more commonly used for the prevension and treatment of osteoporosis. Bisphosphonate-related osteonecrosis of the jaws (BRONJ) has been well documented recently in relation to intravenous preparations of the drug. But, a few cases have been reported of oral bisphosphonate-associated osteonecrosis. We could not find any risedronate cases in the Korean medical literature. Here we report a case of BRONJ in a 91-year-old woman patient receiving an oral bisphosphonate (risedronate) for the treatment of osteoporosis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Osteomalacia
/
Osteonecrose
/
Osteoporose
/
Doenças Ósseas
/
Ácido Etidrônico
/
Difosfonatos
/
Osteonecrose da Arcada Osseodentária Associada a Difosfonatos
/
Ácido Risedrônico
/
Arcada Osseodentária
Limite:
Feminino
/
Humanos
Idioma:
Coreano
Revista:
The Journal of the Korean Orthopaedic Association
Ano de publicação:
2010
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS